Angiodynamics Inc (ANGO) financials

NASDAQ · Health Care

$11.99 -2.92% Close Oct 30, 2026 Live

Angiodynamics revenue and earnings by year

Angiodynamics's revenue was $320 million in the fiscal year to May 31, 2026, up 9.5% from the year before. Net income was -$36.7 million, -11.5% of revenue. Since the fiscal year to May 31, 2017, revenue has grown 1.9% a year on average.

RevenueNet income
-$200M$0$200M
2017201820192020202120222023202420252026

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toMay 2026May 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017
Revenue320292304339316291264271262270
Revenue growth9.5%-3.8%-10.3%7.1%8.7%10.2%-2.4%3.4%-3.0%—
Gross profit175158155174166157150156144144
Gross margin54.6%53.9%50.9%51.4%52.4%53.9%56.9%57.6%55.0%53.4%
Operating income-36-35-193-49-28-35-179-16-14-26
Operating margin-11.2%-11.9%-63.4%-14.6%-8.9%-12.1%-67.7%-6.1%-5.3%-9.8%
Net income-37-34-184-52-27-32-16761165
Net margin-11.5%-11.6%-60.7%-15.5%-8.4%-10.8%-63.1%22.7%6.2%1.9%
Diluted EPS-$0.88-$0.83-$4.59-$1.33-$0.68-$0.82-$4.39$1.61$0.44$0.14
Free cash flow-3-20-155-9-2310-22343953

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ANGO in Markets.

How Angiodynamics makes money

Revenue by segment in the quarter to August 31, 2026, as the company reports it.

SegmentRevenueShare
Med Device$41.0M50.7%
Med Tech$39.9M49.3%

See also: ANGO valuation and P/E history · ANGO returns

No forecast, no recommendation. This page describes Angiodynamics Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.